Literature DB >> 28496785

Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation.

Ethan R Ellis1, Matthew R Reynolds2.   

Abstract

Atrial fibrillation and obesity are interlinked epidemics and both impair quality of life. As the prevalence of both conditions in the US continues to rise, so will the number of obese patients with atrial fibrillation referred for catheter ablation. Catheter ablation has already been shown to significantly improve quality of life in patients with atrial fibrillation. Until recently, there has been little attention to the effects of catheter ablation on quality of life specifically in obese patients with atrial fibrillation. This paper will review what is known about the effects of atrial fibrillation and obesity on quality of life and how quality of life is affected by catheter ablation for atrial fibrillation in obese patients.

Entities:  

Year:  2012        PMID： 28496785      PMCID： PMC5153149          DOI： 10.4022/jafib.426

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  40 in total

Review 1.  The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.

Authors:  S Engeli; A M Sharma
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

2.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

3.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

4.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

5.  Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation.

Authors:  Rukshen Weerasooriya; Pierre Jaïs; Mélèze Hocini; Christophe Scavée; Laurent MacLe; Li Fern Hsu; Prashanthan Sandars; Stephane Garrigue; Jacques Clémenty; Michel Haïssaguerre
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

6.  Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.

Authors:  M Pelat; P Verwaerde; C Merial; J Galitzky; M Berlan; J L Montastruc; J M Senard
Journal:  Hypertension       Date:  1999-11       Impact factor: 10.190

7.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.

Authors:  Krit Jongnarangsin; Aman Chugh; Eric Good; Siddharth Mukerji; Sujoya Dey; Thomas Crawford; Jean F Sarrazin; Michael Kuhne; Nagib Chalfoun; Darryl Wells; Warangkna Boonyapisit; Frank Pelosi; Frank Bogun; Fred Morady; Hakan Oral
Journal:  J Cardiovasc Electrophysiol       Date:  2008-03-21

9.  Obesity paradox in patients with hypertension and coronary artery disease.

Authors:  Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-Dehoff; Qian Zhou; Carl J Pepine
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

Review 10.  Quality of life in atrial fibrillation: measurement tools and impact of interventions.

Authors:  Matthew R Reynolds; Ethan Ellis; Peter Zimetbaum
Journal:  J Cardiovasc Electrophysiol       Date:  2008-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.